The impact of hypertension on the prognosis of patients with hypertrophic cardiomyopathy: a single-center retrospective study
PeerJ · 2023
DOI: 10.7717/peerj.14614 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2023. Verfasst von Ziqiong Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, West China Hospital of Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Heart Failure, Hypertension, Stroke. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sichuan Science and Technology Program, China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Hypertrophic cardiomyopathy (HCM) and hypertension coexist fairly frequently in clinical practice. However, the evidence about the impact of hypertension on the prognosis of HCM is limited. The present study aims to investigate the impact of hypertension on the prognosis of HCM patients.
Methods
A total of 468 HCM patients were enrolled, and patients were divided into hypertension group (31.8%) and non-hypertension group (68.2%). The primary study endpoint was HCM-related death, consisting of heart failure (HF)-related death, stroke-related death and sudden cardiac death (SCD). Associations between hypertension and HCM-related death were analyzed by Cox regression models with the use of propensity score matching (PSM) as primary analysis.
Results
There were 55 HCM-related death during a median follow-up time of 4.6 years, and the mortality rate was 2.53 per 100 person years. Kaplan-Meier analysis based on the crude cohort or PSM cohort revealed no significant difference regarding the HCM-related death between the two groups. In the crude cohort, both univariable and multivariable Cox regression analysis indicated that hypertension was not significantly associated with HCM-related death with hazard ratios (HR) at 0.74 (95% CI [0.40–1.36], p value: 0.329) and 0.77 (95% CI [0.35–1.71], p value: 0.521), respectively. Similarly, no strong evidence for an association was observed between hypertension and HCM-related death in the PSM cohort with unadjusted HR at 0.90 (95% CI [0.34–2.41]; p value: 0.838) and adjusted HR at 0.77 (95% CI [0.35–1.71]; p value: 0.521), respectively. Other propensity score methods, including overlap weighting and inverse probability treatment weighting demonstrated similar results. Sensitivity analysis also indicated that the concomitant hypertension did not significantly increase the risk of HF-related death, stroke-related death or SCD in HCM patients.
Conclusion
HCM-related death did not significantly differ between hypertension and non-hypertension groups, suggesting a negative impact of hypertension on the clinical prognosis of HCM patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, West China Hospital of Sichuan University, Chengdu, China.
- Department of Cardiology, Hospital of Traditional Chinese Medicine, Shuangliu District, Chengdu, Sichuan, China.
- Department of Cardiology, First People's Hospital, Longquanyi District, Chengdu, Sichuan, China.
Förderung
- Sichuan Science and Technology Program, China
- National Natural Science Foundation of China
Zitieren
APA
Wang, Z., Zheng, Y., Ruan, H., Li, L., Zhang, M., Duan, L., & He, S. (2023). The impact of hypertension on the prognosis of patients with hypertrophic cardiomyopathy: a single-center retrospective study. PeerJ. https://doi.org/10.7717/peerj.14614
Vancouver
Wang Z, Zheng Y, Ruan H, Li L, Zhang M, Duan L, et al. The impact of hypertension on the prognosis of patients with hypertrophic cardiomyopathy: a single-center retrospective study. PeerJ. 2023. doi:10.7717/peerj.14614
BibTeX
@article{Wang2023,
author = {Wang, Ziqiong and Zheng, Yi and Ruan, Haiyan and Li, Liying and Zhang, Muxin and Duan, Linjia and He, Sen},
title = {The impact of hypertension on the prognosis of patients with hypertrophic cardiomyopathy: a single-center retrospective study},
journal = {PeerJ},
year = {2023},
doi = {10.7717/peerj.14614}
}
EUVIMED